Linkus Nova Lozenges Orange Flavor
Linkus Nova Lozenges Orange Flavor : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20086101T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- Herbion Sdn. Bhd.
- Manufacturer
- Herbion Pakistan (Pvt.) Ltd
- Importer
- Herbion Sdn. Bhd.
- Registration period starting
- 2025-08-22
- Published validity end
- 2030-08-22
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Adhatoda vasica | Adhatoda vasica[243 mg,2.5 gm] | Not identified |
| Alpinia galanga | Alpinia galanga[20 mg,2.5 gm] | Not identified |
| Piper longum | Piper longum[40.5 mg,2.5 gm] | Not identified |
| Cordia latifolia | Cordia latifolia[40.5 mg,2.5 gm] | Not identified |
| Hyssopus officinalis | Hyssopus officinalis[20 mg,2.5 gm] | Not identified |
| Viola odorata | Viola odorata[10 mg,2.5 gm] | Not identified |
| Glycyrrhiza glabra | Glycyrrhiza glabra[10 mg,2.5 gm] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Adhatoda vasica[243 mg,2.5 gm],Alpinia galanga[20 mg,2.5 gm],Piper longum[40.5 mg,2.5 gm],Cordia latifolia[40.5 mg,2.5 gm],Hyssopus officinalis[20 mg,2.5 gm],Viola odorata[10 mg,2.5 gm],Glycyrrhiza glabra[10 mg,2.5 gm]
- Valid until
- 2030-08-22
- Registration date
- 2025-08-22
- Published description
- NATURAL PRODUCT
- Licence holder
- Herbion Sdn. Bhd.
- Importer
- Herbion Sdn. Bhd.
- Producer
- Herbion Pakistan (Pvt.) Ltd
- Published name
- Linkus Nova Lozenges Orange Flavor
- Published reference
- 201906032205T
- Registration number
- MAL20086101T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20086101T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Hyssopus officinalis
Read the warning, when it applies and the studies cited
Hyssop - Hyssop Officinalis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Do not use if you are pregnant (Gardner and McGuffin 2013; Bradley 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Glycyrrhiza glabra
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.